Aspire Biopharma Holdings, Inc. Common Stock (ASBP)
search
Earnings reactions
How ASBP moved on each past earnings report.
Up
Down
Earnings Impact
Aspire Biopharma Holdings, Inc. Common Stock (ASBP) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
Historical Earnings Statistics
Aspire Biopharma Holdings, Inc. Common Stock (ASBP) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
event
Earnings Count
0
Total earnings in dataset
trending_up
Avg Abs. Movement
±0.00%
Avg % price change on earnings
account_balance
View all 4 →
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
4
Funds holding
$88572
Total value held
Buying
4 added · 0 reduced
Morgan Stanley
$79264
NEW BUY
Toronto Dominion Bank
$5150
NEW BUY
Jpmorgan Chase & Co
$4013
+173.00%
Barclays Plc
$145
NEW BUY
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260720 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260702 | open_in_new SEC.gov |
| 8-K | 20260622 | open_in_new SEC.gov |
| 8-K | 20260612 | open_in_new SEC.gov |
| 8-K | 20260612 | open_in_new SEC.gov |
| 10-Q | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260515 | open_in_new SEC.gov |
| 8-K | 20260514 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260513 | open_in_new SEC.gov |
| CORRESP | 20260413 | open_in_new SEC.gov |